GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XBUL:22UA) » Definitions » Accumulated other comprehensive income (loss)

BioNTech SE (XBUL:22UA) Accumulated other comprehensive income (loss) : лв-2,822 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BioNTech SE Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. BioNTech SE's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2024 was лв-2,822 Mil.

BioNTech SE's quarterly Accumulated other comprehensive income (loss) declined from Mar. 2024 (лв-1,957 Mil) to Jun. 2024 (лв-2,126 Mil) and declined from Jun. 2024 (лв-2,126 Mil) to Sep. 2024 (лв-2,822 Mil).

BioNTech SE's annual Accumulated other comprehensive income (loss) declined from Dec. 2021 (лв202 Mil) to Dec. 2022 (лв-1,711 Mil) and declined from Dec. 2022 (лв-1,711 Mil) to Dec. 2023 (лв-2,042 Mil).

BioNTech SE Accumulated other comprehensive income (loss) Historical Data

The historical data trend for BioNTech SE's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Accumulated other comprehensive income (loss) Chart

BioNTech SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accumulated other comprehensive income (loss)
Get a 7-Day Free Trial 10.20 58.78 201.82 -1,710.54 -2,042.39

BioNTech SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accumulated other comprehensive income (loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,836.80 -2,042.39 -1,957.37 -2,125.76 -2,822.22

BioNTech SE Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

BioNTech SE Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XBUL:22UA) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
ALNY BGNE UTHR MRNA NEUP SMMT INCY BMRN INSM SRPT VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX XKRX:068270 OCSE:GMAB SHSE:603392 TECH
Traded in Other Exchanges
BNTX:USA BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria
Address
An der Goldgrube 12, Mainz, RP, DEU, D-55131
Website
https://www.biontech.de
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

BioNTech SE Headlines

No Headlines